Emergence of New Classes of Recreational Drugs—Synthetic Cannabinoids and Cathinones

被引:0
|
作者
Vikas Khullar
Ankur Jain
Maryam Sattari
机构
[1] University of Florida College of Medicine,Department of Medicine
来源
关键词
designer drugs; synthetic cathinones; bath salts; synthetic cannabinoids;
D O I
暂无
中图分类号
学科分类号
摘要
Designer drugs represent an increasingly popular form of recreational substance abuse, especially amongst young adults. The two classes of designer drugs that have recently risen to prominence are the synthetic cannabinoids and synthetic cathinones. These substances are not detected by conventional drug screening methods and can often be associated with serious health consequences, including seizures, renal failure and death. Thus, clinicians should be familiar with the signs, symptoms, and toxicities associated with the use of these substances, and maintain a high level of suspicion for synthetic drugs as an alternative means of “getting high.” We present a case of a 20-year-old college student who presented to the emergency department with altered mental status and severe agitation who later admitted to using bath salts. The goal of this article is to raise awareness about these new designer drugs, their clinical presentation, and management of their intoxication.
引用
收藏
页码:1200 / 1204
页数:4
相关论文
共 50 条
  • [41] Emergence of meta-chlorophenylpiperazine (mCPP) in recreational drugs
    Debruyne, D.
    Parent, M-J
    Lahaie, E.
    Le Boisselier, R.
    Coquerel, Antoine
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 : 97 - 97
  • [42] Detection and Quantification of New Designer Drugs in Human Blood: Part 1 Synthetic Cannabinoids
    Ammann, Julia
    McLaren, Jenna M.
    Gerostamoulos, Dimitri
    Beyer, Jochen
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2012, 36 (06) : 372 - 380
  • [43] New Drugs of Abuse: Acute Intoxication by Smoking Herbal Products Containing Synthetic Cannabinoids
    Hermanns-Clausen, M.
    Kneisel, S.
    Auwaerter, V
    CLINICAL TOXICOLOGY, 2011, 49 (03) : 199 - 199
  • [44] Isomeric Analysis of Synthetic Cannabinoids Detected as Designer Drugs
    Uchiyama, Nahoko
    Kikura-Hanajiri, Ruri
    Shoda, Takuji
    Fukuhara, Kiyoshi
    Goda, Yukihiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (07): : 1141 - 1147
  • [45] Emerging drugs of abuse: current perspectives on synthetic cannabinoids
    Debruyne, Daniele
    Le Boisselier, Reynald
    SUBSTANCE ABUSE AND REHABILITATION, 2015, 6 : 113 - 129
  • [46] Synthetic Cannabinoids as Designer Drugs: A Structural Overview.
    Mahadevan, A.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 : S20 - S20
  • [47] The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines
    Tyrkko, Elli
    Andersson, Mikael
    Kronstrand, Robert
    THERAPEUTIC DRUG MONITORING, 2016, 38 (02) : 190 - 216
  • [48] SINTES 2021 update: intensification of the circulation of synthetic cannabinoids and cathinones, cocaine levels which remain high
    Cherki, Sabrina
    THERAPIE, 2022, 77 (06): : 764 - 764
  • [49] Phytocanabinoids and synthetic cannabinoids: from recreational consumption to potential therapeutic use - a review
    Teixeira, Helena M.
    FRONTIERS IN TOXICOLOGY, 2025, 6
  • [50] New Zealand bans synthetic cannabinoids
    Brown, Karen
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343